Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous VSELs for Facial Skin Antiaging
NCT03976206Phase 2Withdrawn
- Sponsor
- Fuda Cancer Hospital
- Start
- Jul 2019
- Primary completion
- May 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of very small embryonic-like stem cells in Skin aging, sponsored by Fuda Cancer Hospital. Planned start Jul 2019; status: withdrawn.
02
Drugs
very small embryonic-like stem cells
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT03976206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03976206.